The Vigabatrin REMS Program is needed by the FDA to make sure educated risk-benefit decisions before starting therapy, and to make certain appropriate use of vigabatrin while patients are treated. It is not possible for your doctor to know when vision loss will occur.
It is suggested that your healthcare provider examination your (or your kid's) vision before or within 4 weeks after starting SABRIL and a minimum of every 3 months during treatment up until SABRIL is quit. If you or your kid have any kind of side effect that bothers you or that does not go away, inform your medical care provider.
Tell your healthcare provider if you are pregnant or intend to obtain expectant. If vision testing can not be done, your doctor may continue prescribing SABRIL, yet will not have the ability to look for any vision loss. Your healthcare service provider may stop recommending SABRIL for you (or your child)if vision tests are not done routinely.